Cardiovascular risk assessment
| N=40 | |
| Systolic BP (mm Hg) | 144 (±19) |
| Diastolic BP (mm Hg) | 80 (±11) |
| ECG parameters | |
| Heart rate | 72 (±12) |
| Sinus rhythm | 40 (100%) |
| PR interval (ms) | 157 (144–167) |
| QRS duration (ms) | 76 (74–84) |
| QTc interval (ms) | 429 (415.5–440.5) |
| Blood results | |
| Total cholesterol (mmol/L) | 5.9 (±1.3) |
| HDL (mmol/L) | 1.6 (±0.4) |
| Total cholesterol:HDL ratio | 3.4 (2.8–4.3) |
| Triglycerides (mmol/L) | 1.5 (1.0–2.4) |
| HbA1c (mmol/mol) | 37 (36–41) |
| Total cholesterol >5.0 mmol/L | 23 (58%) |
| Total cholesterol:HDL ratio >4 | 11 (28%) |
| HDL <1.0 mmol/L | 1 (3%) |
| LDL >3.0 mmol/L | 19 (48%) |
| Triglycerides >1.7 mmol/L | 17 (43%) |
| HbA1c >42 mmol/mol | 2 (5%) |
Data are presented as mean±SD or median (IQR) for continuous measures (dependent on distribution) and n (%) for categorical measures.
BP, blood pressure; HbA1c, glycosylated haemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein.